ESCMID Global 2026

ESCMID Global 2026 is one of the leading international congresses in the field of infectious diseases and clinical microbiology, bringing together healthcare professionals, researchers and industry experts from around the world. The event provides a key platform to explore how diagnostics and clinical insights can support better decision-making in infection management.

Sysmex will be exhibiting at Booth D72, Hall B1, with a strong focus on supporting clinical decision-making through diagnostics. Our presence is organised into four thematic hubs, showcasing how different diagnostic disciplines contribute to a more integrated and efficient approach to patient care.

At our booth, visitors can explore solutions from our Point of Care, Urinalysis, Haematology, and Life Science business lines. The exhibited portfolio addresses key aspects of infectious disease management, including UTI and infection management, host response to infection and PCR-based microbiological testing, demonstrating how Sysmex diagnostics support evidence-based clinical decisions across care settings.

In addition, Sysmex will officially introduce the geneLEAD VIII platform together with SMD lead kits. This product launch represents an important expansion of our molecular diagnostics portfolio and highlights our commitment to automation and workflow efficiency, supporting timely and confident clinical decision-making in infectious disease management.

We look forward to welcoming you at ESCMID Global 2026 and exchanging insights on the role of diagnostics in modern healthcare. 

#ESCMID #Sysmex #microbiology